Approaching the third decade of paediatric palliative oncology investigation: historical progress and future

Abby R Rosenberg1, Joanne Wolfe1

  • 1Seattle Children's Hospital Cancer and Blood Disorders Center, Seattle, WA, USA (A R Rosenberg MD); Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA (A R Rosenberg); Treuman Katz Center for Pediatric Bioethics, Seattle Children's Research Institute, Seattle, WA, USA (A R Rosenberg); Department of Psychosocial Oncology and Palliative Care, and Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA, USA (J Wolfe MD); Department of Medicine, Boston Children's Hospital, Boston, MA, USA (J Wolfe); and Harvard Medical School, Boston, MA, USA (J Wolfe).

Insights

Paediatric palliative care (PPC) research has advanced significantly over two decades. Studies now focus on the entire cancer journey, improving quality of life for children and their families.

Area of Science:

  • Pediatric Oncology
  • Palliative Care Research

Background:

  • The World Health Organization (WHO) defined Paediatric Palliative Care (PPC) two decades ago, advocating for its integration into pediatric oncology.
  • Initial research focused on end-of-life care, identifying symptom burden and barriers to communication.

Purpose of the Study:

  • To review the evolution and key findings of PPC research over the past 20 years.
  • To highlight the expansion of research scope and the identification of new support needs.

Main Methods:

  • Literature review and synthesis of research findings over two decades.
  • Analysis of the progression of research focus from end-of-life to the entire cancer continuum.

Main Results:

  • Early research highlighted symptom burden and communication challenges in end-of-life care.
  • Later research expanded to include the full cancer continuum, patient voices, and support for siblings and minority groups.
  • Randomized clinical trials have tested interventions to improve outcomes.

Conclusions:

  • PPC research has evolved substantially, providing critical insights into improving care for children with serious illnesses.
  • Future research should continue to address the burdens associated with pediatric cancer and enhance supportive care strategies.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Directing Effect of Substituents: meta-Directing Groups01:09

Directing Effect of Substituents: meta-Directing Groups

Substituents on the benzene ring that direct an incoming electrophile to undergo substitution at the meta position are called meta directors. All meta directors either have a positive charge on the atom directly bonded to the ring or a partial positive charge. These groups function by withdrawing electrons from the ring through inductive and resonance effects. Consider the carbocation intermediates formed upon the addition of an electrophile on nitrobenzene at the...
6.1K
Frustration and Conflict: Approach-Approach, Approach-Avoidance01:20

Frustration and Conflict: Approach-Approach, Approach-Avoidance

Frustration occurs when people are obstructed or prevented from achieving a desired goal or fulfilling a perceived need. For example, when someone's input is ignored in a discussion, it can lead to feelings of frustration. Conflict, however, arises from opposing interests, goals, or actions. Conflicts can take various forms based on the nature of these opposing desires or goals.
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
557
Directing Effect of Substituents: ortho–para-Directing Groups01:14

Directing Effect of Substituents: orthopara-Directing Groups

Ortho–para directors are substituent groups attached to the benzene ring and direct the addition of an electrophile to the positions ortho or para to the substituent. All electron-donating groups are considered ortho–para directors. They donate electrons to the ring and make the ring more electron-rich. The ring is therefore susceptible to the addition of electrophiles. Substituents such as amino, hydroxy, or alkoxy, containing lone pairs on the atom adjacent to the ring, donate...
8.7K
Directional Terms01:14

Directional Terms

Directional terms are essential for describing the relative locations of different body structures. For instance, an anatomist might describe one band of tissue as "inferior to" another, or a physician might describe a tumor as "superficial to" a deeper body structure. These terms often use comparative terms in pairs to trace out the relative locations of one body part to another or descriptions of body tissues like the deeper ones from superficially present with reference to...
17.2K